BioSpace News Archive

ARKRAY USA, Inc. announced today that the Company’s Long-term Care Division will be renamed the Professional Healthcare Division.

RES, recognized as one of the fastest-growing private companies in the US, strengthens its resources.

Apply for IRB review through the American Academy of Stem Cell Physicians

reSET-O™ is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder

Ra Pharmaceuticals, Inc. today announced that it intends to offer and sell, subject to market and other conditions, $100 million of its common stock in an underwritten public offering.

Varian today announced that it will report results for the first quarter of fiscal year 2019 after market close on Wednesday, January 23, 2019.

Get Active. Get Healthy. Get Happy. From Indoor and Outdoor Runs to Special Workouts - Commitment Day is About Inspiring Health with 141 Clubs Open Nationwide and in Canada

Recent Reimbursement Cuts Emphasize Value of Enzo’s Strategy

Puma Biotechnology, Inc. announced that in connection with the appointment of Maximo F. Nougues as Puma’s Chief Financial Officer, the Compensation Committee of Puma’s Board of Directors approved a grant to Mr. Nougues of an inducement stock option to purchase 90,000 shares of Puma common stock, at an exercise price per share equal to the closing price of Puma’s common stock on the grant date.

Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the appointment of William (Bill) Monteith to the role of Senior Vice President U.S. Manufacturing.